BioNexus Gene Lab (BGLC) Receivables - Other (2018 - 2026)
BioNexus Gene Lab recorded quarterly Receivables - Other of $88983.0 in Q1 2026, up 8.88% quarter-over-quarter from $81728.0 in Q4 2025, and down 62.25% year-over-year from $235727.0 in Q1 2025.
BioNexus Gene Lab's Receivables - Other history runs 9 years deep, the most recent figure standing at $88983.0 for Q1 2026.
- In Q1 2026, Receivables - Other fell 62.25% year-over-year to $88983.0; the TTM figure through Mar 2026 stood at $88983.0 (down 62.25% YoY), while the FY2025 annual figure was $81728.0, down 59.87% from the prior year.
- Receivables - Other came in at $88983.0 for Q1 2026 at BioNexus Gene Lab, up from $81728.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $400830.0 in Q2 2024 to a low of $25240.0 in Q4 2022.
- A 5-year average of $117299.5 and a median of $88983.0 in 2026 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other slumped 68.26% in 2022 and jumped 744.19% in 2024, its largest moves.
- BioNexus Gene Lab's Receivables - Other stood at $25240.0 in 2022, then jumped by 385.07% to $122432.0 in 2023, then surged by 66.35% to $203660.0 in 2024, then plunged by 59.87% to $81728.0 in 2025, then advanced by 8.88% to $88983.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $88983.0, $81728.0, and $98903.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,983.00 |
| Mar 31, 2026 | 88,983.00 |
| Dec 31, 2025 | 81,728.00 |
| Dec 31, 2025 | 81,728.00 |
| Sep 30, 2025 | 98,903.00 |
| Sep 30, 2025 | 98,903.00 |
| Jun 30, 2025 | 151,269.00 |
| Jun 30, 2025 | 151,269.00 |
| Mar 31, 2025 | 235,727.00 |
| Mar 31, 2025 | 235,727.00 |
| Dec 31, 2024 | 203,660.00 |
| Dec 31, 2024 | 203,660.00 |
| Sep 30, 2024 | 65,683.00 |
| Sep 30, 2024 | 65,683.00 |
| Jun 30, 2024 | 400,830.00 |
| Jun 30, 2024 | 400,830.00 |
| Mar 31, 2024 | 106,304.00 |
| Mar 31, 2024 | 106,304.00 |
| Dec 31, 2023 | 122,432.00 |
| Dec 31, 2023 | 122,432.00 |
| Sep 30, 2023 | 110,793.00 |
| Sep 30, 2023 | 110,793.00 |
| Jun 30, 2023 | 47,481.00 |
| Jun 30, 2023 | 47,481.00 |
| Mar 31, 2023 | 29,346.00 |
| Mar 31, 2023 | 29,346.00 |
| Dec 31, 2022 | 25,240.00 |
| Dec 31, 2022 | 25,240.00 |
| Sep 30, 2022 | 72,600.00 |
| Sep 30, 2022 | 72,600.00 |
| Jun 30, 2022 | 81,587.00 |
| Jun 30, 2022 | 81,587.00 |
| Mar 31, 2022 | 71,525.00 |
| Mar 31, 2022 | 71,525.00 |
| Dec 31, 2021 | 79,517.00 |
| Dec 31, 2021 | 79,517.00 |
| Sep 30, 2021 | 23,426.00 |
| Sep 30, 2021 | 23,426.00 |
| Jun 30, 2021 | 29,355.00 |
| Jun 30, 2021 | 29,355.00 |
| Mar 31, 2021 | 22,933.00 |
| Mar 31, 2021 | 22,933.00 |
| Dec 31, 2020 | 22,640.00 |
| Dec 31, 2020 | 22,640.00 |
| Sep 30, 2020 | 13,847.00 |
| Sep 30, 2020 | 13,847.00 |
| Jun 30, 2020 | 13,166.00 |
| Jun 30, 2020 | 13,166.00 |
| Mar 31, 2020 | 13,927.00 |
| Mar 31, 2020 | 13,927.00 |
| Dec 31, 2019 | 13,057.00 |
| Dec 31, 2019 | 13,057.00 |
| Sep 30, 2019 | 26,693.00 |
| Sep 30, 2019 | 26,693.00 |
| Jun 30, 2019 | 24,451.00 |
| Jun 30, 2019 | 24,451.00 |
| Mar 31, 2019 | 26,784.00 |
| Mar 31, 2019 | 26,784.00 |
| Dec 31, 2018 | 22,814.00 |
| Dec 31, 2018 | 22,814.00 |